-
Stocks mostly rise tracking earnings, US-Iran hopes
-
Alarm at German airport after drone found near Ukrainian plane, mid-air incident
-
Pakistan team reaches base camp with body of renowned climber killed in avalanche
-
Salah arrives in Turkey for Trabzonspor talks
-
Ceuta warns of 'unsustainable' situation for child migrants after influx
-
Embattled FIFA chief Infantino holds emergency talks with directors
-
SpaceX rocket stage believed to have slammed into Moon
-
Russian barrage on Kyiv kills 17 as Ukraine fails to down single missile
-
India monsoon floods, landslides kill more than 100 since July: officials
-
'Lost': Migrants despair after Britain expels them back to France
-
South Korea pro baseball league cancels games over heatwave
-
Cathay Pacific's profit soars 71% despite Iran war driving up fuel costs
-
Taiwan probes 17 China-funded firms over high-tech talent poaching
-
Russian barrage on Ukraine kills 15, wounds dozens more
-
Trump warns Iran to open Hormuz or get 'hit very hard'
-
South Korea police raid Starbucks HQ over 'Tank Day' fiasco
-
Factories shed workers in Bangladesh garment sector
-
Tech back in fashion as Asian markets extend rebound
-
North Korea warns of 'military options' over Japan rearmament
-
Total eclipse gives scientists chance to probe Sun's mysteries
-
Tiny light, big dream: Harvesting power from soil in Japan
-
What to know about the total solar eclipse on August 12
-
Trump admin to review 'closed' AI models before release: reports
-
'Like the end of the world': the eclipse chasers flocking to Spain
-
De Minaur fights past Duckworth in all-Aussie Montreal battle
-
Taiwan begins military drills as China pressure grows
-
High bills, cheap panels drive a Philippine solar surge
-
UK mansion where 'listeners' spied on Nazi generals becomes museum
-
Russian barrage on Ukraine kills 2, wounds dozens more
-
Sabalenka tops Uchijima in WTA Toronto opener
-
RE Royalties Announces Third Investment in Solaris Energy's Portfolio and Letter of Intent for Expanded Royalty Partnership for a Further US$62.7 Million
-
Alcaraz withdraws from Cincinnati Masters with wrist injury
-
Kgatlana strikes as South Africa reach WAFCON quarter-finals
-
SpaceX revenue jumps 92% in first earnings report, but shares slide
-
Pakistan close on series-levelling win against West Indies
-
US eyes Hormuz deal 'today or tomorrow' as ship sinks in Red Sea
-
Paramount CEO says politics fueling Warner Bros. merger battle
-
SpaceX revenue jumps 92% in first earnings report
-
Trump's sale of access to Truth Social raises eyebrows
-
New commissioner Berg wants to take MLS to 'next level'
-
SpaceX rocket stage expected to slam into Moon
-
Colombian ex-guerrillas fear for future under hardline president
-
US hopeful Hormuz strait deal will be done 'today or tomorrow'
-
Tsitsipas comeback continues with Montreal first-round win
-
Michigan primary puts Democratic divide on the ballot
-
Swiatek fends off Bejlek to reach Toronto third round
-
South Africa captain Kolisi to make Test return in Argentina
-
Reusser romps to overall lead at Tour de France Femmes
-
Cuba's famed resilience comes at a growing mental cost
-
McDonald's reports slower US sales in 2nd quarter
Fourth jab 'partially' effective against Omicron: Israeli study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
A team from Sheba Medical Center near Tel Aviv began conducting a trial in December on fourth doses of coronavirus vaccines, inoculating 154 hospital personnel with Pfizer jabs and 120 other volunteers with Moderna doses.
Preliminary results of the trial "have shown that the vaccines are safe and have shown to produce substantial antibodies, but are only partially effective in defending against the Omicron variant," the hospital said in a statement.
Professor Gili Regev-Yochay, who leads the study, said that while there was an increase in antibodies after administering a fourth dose, it nonetheless "only offers a partial defenser against the virus" for those infected with the Omicron variant.
The vaccines were "extremely effective against the earlier variants," Regev-Yochay noted.
Israel was among the first countries to launch mass immunisation campaigns for its population.
It then began offering booster shots last summer, and has since greenlighted fourth shots for elderly and vulnerable populations.
More than 537,000 Israelis have received a fourth dose of vaccine, according to the health ministry's latest figures.
More than 80 percent of Israel's adult residents have received two coronavirus vaccine shots and more than half have also been given a booster.
- Reduced quarantine -
Meanwhile, the Israeli government on Monday said it was reducing the quarantine period for positive cases from seven to five days, as a record number of infections threatens to overburden the economy.
"This decision will enable us to continue safeguarding public health on the one hand and to keep the economy going at this time on the other, even though it is difficult," Prime Minister Naftali Bennett said in a short video message sent by his office.
Faced with skyrocketing infections fuelled by the Omicron variant, Israel has become the latest country to reduce quarantine periods, after similar moves from France, Spain, Argentina, the United States and Britain.
Israel shuttered its borders after discovering one case infected with the Omicron variant in November, but reopened in early January, despite a spike in infections.
In total, more than 1.7 million infections have been recorded since the start of the pandemic in Israel, including more than 8,300 deaths, according to official figures.
P.Queiroz--PC